Tickerover
Healthcare

ENSG Stock Analysis

The Ensign Group, Inc. · current price $172.96 (-0.38% today)

Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
★★★
Average
📊

The six-pillar scorecard

Momentum
45
Losing steam
price trend
Growth
26
Barely growing
sales & profit growth
Quality
57
Solid fundamentals
profitability & balance sheet
Valuation
75
Looks cheap
is the price fair?
Sentiment
47
Mixed views
analyst & crowd mood
Risk
73
Low risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
GrowthGrowth: 7070Near 52w highNear 52w high: 8888Analyst consensusAnalyst consensus: 7070Earnings qualityEarnings quality: 7878News sentimentNews sentiment: 9595Relative strengthRelative strength: 45451-month momentum1-month momentum: 3030
Margin profileWhat survives each step down the income statement.
GrossGross: 16.6%16.6%OperatingOperating: 9.0%9.0%NetNet: 6.9%6.9%Free cash flowFree cash flow: 7.6%7.6%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +4.0% vs estimate+4%2026-062026-03: +1.8% vs estimate+2%2026-032025-12: +3.0% vs estimate+3%2025-122025-09: +2.1% vs estimate+2%2025-09
👁

Hype Check

Reading ENSG’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading ENSG’s filings…

📣

Latest earnings

LAST EARNINGS The Ensign Group, Inc. (ENSG)

Latest earnings

EPS
$1.64 vs $1.61 est · +2.1% vs estimate BEAT
Revenue
$1.44B · +11.1% YoY
Stock reaction (1M)
-3.3%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
27.2×
Forward P/E
20.2×
PEG
1.50
Price / Sales
1.8×
Price / Book
4.1×
EV / EBITDA
20.5×
Analyst target
$220.00
Target range
$207.00 – $230.00
Implied upside
+27.2%
🩺

Financial health

Gross margin
16.6%
Operating margin
9.0%
Net margin
6.9%
FCF margin
7.6%
Return on equity
17.0%
Debt / equity
0.92
Revenue growth YoY
+17.3%
EPS growth YoY
+16.7%
📈

Technicals

$141.5852-week range$218.00
RSI (14)
40
50-day MA
$173.11
200-day MA
$182.50
ATR (14)
4.23
Beta
0.69
1-month return
-3.3%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$1.64$1.61+2.1%Beat
2025-12-31$1.82$1.77+3.0%Beat
2026-03-31$1.85$1.82+1.8%Beat
2026-06-30$1.92$1.85+4.0%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.03%
Dividend yield
0.15%
Beta
0.69
📰

Latest news on ENSG

🔗

Similar stocks in Healthcare

Frequently asked

What is ENSG's Quant Score?

The Ensign Group, Inc. (ENSG) currently has a TickerMover Quant Score of 55/100, rated ★★★ Average. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is The Ensign Group, Inc. (ENSG) a buy?

TickerMover does not give buy or sell recommendations. ENSG scores 55/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is ENSG's score updated?

ENSG's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for ENSG →